Silo Pharma Expands Crypto Treasury with First Strategic Bitcoin Purchase Reinforcing Company's Commitment to Multi-Chain Growth Nanotech Investing
Anixa Biosciences Announces Completion of Final Patient Visit in Breast Cancer Vaccine Clinical Trial Nanotech Investing
Longeveron® to Participate in the 4th Annual ROTH Healthcare Opportunities Conference Nanotech Investing
Silo Pharma Acquires ResearchCoin Crypto Tokens in Support of Decentralized Science Nanotech Investing
Silo Pharma Announces Closing of $2.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules Nanotech Investing
George Paletta, Jr., MD, MBA, Internationally Acclaimed Entrepreneur, Investor and Surgeon, Elected to Longeveron® Board of Directors Nanotech Investing
Univest Securities, LLC Announces Closing of $41 Million Strategic Investment in Client Qualigen Therapeutics from Client Faraday Future Nanotech Investing
Vaxcyte to Establish Fill-Finish Manufacturing in North Carolina as Key Element of Long-Term United States Commercial Supply Strategy Representing Up to $1 Billion in Manufacturing and Services Nanotech Investing
Silo Pharma Announces $2.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules Nanotech Investing
Nuvation Bio Enrolls First Patient in TRUST-IV Phase 3 Study of IBTROZI for the Adjuvant Treatment of ROS1-Positive Early-Stage Non-Small Cell Lung Cancer Nanotech Investing
